More insights into the mechanism(s) of the intravenous immunoglobulin effect in autoimmunity

S Pollack¹

Affiliations

Review

S Pollack. Isr J Med Sci. 1992 Feb.

. 1992 Feb;28(2):130-2.

S Pollack¹

¹ Division of Clinical Immunology and Allergy, Rambam Medical Center, Haifa, Israel.

No abstract available

Similar articles

Manipulating the immune system with immune globulin.
Dwyer JM. Dwyer JM. N Engl J Med. 1992 Jan 9;326(2):107-16. doi: 10.1056/NEJM199201093260206. N Engl J Med. 1992. PMID: 1727218 Review. No abstract available.
[Anti-idiotype suppression of autoimmunity by therapeutic intravenous immunoglobulins].
Rossi F, Dietrich G, Kazatchkine M. Rossi F, et al. Ann Med Interne (Paris). 1988;139(5):359-68. Ann Med Interne (Paris). 1988. PMID: 3144223 French. No abstract available.
[High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results].
Aymard JP, Ferry R, Janot C, Schooneman F, Streiff F. Aymard JP, et al. Ann Med Interne (Paris). 1990;141(8):689-97. Ann Med Interne (Paris). 1990. PMID: 2091513 Review. French. No abstract available.
[Intravenous immunoglobulins in pediatrics].
Fontán G. Fontán G. An Esp Pediatr. 1986 Aug;25(2):77-9. An Esp Pediatr. 1986. PMID: 3752750 Spanish. No abstract available.
Innovative uses of intravenous immunoglobulins in clinical hematology. Symposium. December 5, 1986, San Francisco, California. Proceedings.
[No authors listed] [No authors listed] Am J Med. 1987 Oct 23;83(4A):1-56. Am J Med. 1987. PMID: 3118702 No abstract available.